Variant report

Variant	rs138233963
Chromosome Location	chr9:21971430-21971431
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr9:21964929-21971504	Hela-S3	cervix:	n/a	n/a
2	POLR2A	chr9:21971169-21971604	PFSK-1	brain:	n/a	n/a
3	POLR2A	chr9:21970924-21971539	Hela-S3	cervix:	n/a	n/a
4	POLR2A	chr9:21971349-21971625	H1-neurons	neurons:	n/a	n/a
5	SUZ12	chr9:21964929-21971601	NT2-D1	testis:	n/a	n/a
6	POLR2A	chr9:21971268-21971499	Hela-S3	cervix:	n/a	n/a

Variant related genes	Relation type
CDKN2A	TF binding region

Extended variants
information (count: 8 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv529609	chr9:21708371-22537069	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Bivalent/Poised TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
2	nsv8426	chr9:21763810-22176200	Weak transcription Strong transcription Active TSS Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
3	nsv892745	chr9:21857244-22006273	Bivalent Enhancer Enhancers Strong transcription ZNF genes & repeats Weak transcription Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
4	esv1821117	chr9:21933029-22012229	Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
5	nsv1018514	chr9:21944275-22075326	Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
6	nsv892746	chr9:21953137-22028801	Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
7	esv3492902	chr9:21971026-22006145	Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
8	esv3492901	chr9:21971095-22006263	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:32 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:21965400-21972000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr9:21966200-21972000	Strong transcription	Dnd41	blood
3	chr9:21969000-21971600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
4	chr9:21970600-21971600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
5	chr9:21970800-21971600	Bivalent Enhancer	Fetal Heart	heart
6	chr9:21970800-21971800	Strong transcription	Hela-S3	cervix
7	chr9:21970800-21972200	Weak transcription	HSMMtube	muscle
8	chr9:21971200-21971600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
9	chr9:21971200-21971600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
10	chr9:21971200-21971600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
11	chr9:21971200-21971600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr9:21971200-21971600	Bivalent Enhancer	Fetal Intestine Small	intestine
13	chr9:21971200-21971600	Bivalent Enhancer	Placenta	Placenta
14	chr9:21971200-21971600	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
15	chr9:21971200-21972600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr9:21971200-21973600	Weak transcription	HMEC	breast
17	chr9:21971400-21971600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
18	chr9:21971400-21971600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
19	chr9:21971400-21971600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
20	chr9:21971400-21971600	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
21	chr9:21971400-21971600	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr9:21971400-21971600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr9:21971400-21971600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
24	chr9:21971400-21971600	Bivalent Enhancer	Adipose Nuclei	Adipose
25	chr9:21971400-21971600	Bivalent Enhancer	NHLF	lung
26	chr9:21971400-21971800	Weak transcription	GM12878-XiMat	blood
27	chr9:21971400-21972000	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
28	chr9:21971400-21972000	Enhancers	HSMM	muscle
29	chr9:21971400-21972200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
30	chr9:21971400-21972200	Bivalent Enhancer	Osteobl	bone
31	chr9:21971400-21973000	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
32	chr9:21971400-21973400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links